| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of the American Podiatric Medical Association, Vol 84, Issue 9 439-447, Copyright © 1994 by American Podiatric Medical Association
JOURNAL ARTICLE |
JS James and JC Page
Department of Podiatry, Southwest Medical Associates, Las Vegas, NV 89114-5645.
The stepwise approach to the treatment of painful diabetic peripheral neuropathy allows the practitioner to use a broad spectrum of therapeutic modalities and physiologic approaches to this complicated clinical problem. The authors review the etiology and clinical presentation of diabetic neuropathy. Available therapeutic alternatives are discussed and an original stepwise algorithm is presented. Pharmacologic profiles of the most commonly used drugs are also described.
This article has been cited by other articles:
![]() |
M. J. Field, M. I. Gonzalez, R. J. Tallarida, and L. Singh Gabapentin and the Neurokinin1 Receptor Antagonist CI-1021 Act Synergistically in Two Rat Models of Neuropathic Pain J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 730 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Field, S. McCleary, P. Boden, N. Suman-Chauhan, J. Hughes, and L. Singh Involvement of the Central Tachykinin NK1 Receptor during Maintenance of Mechanical Hypersensitivity Induced by Diabetes in the Rat J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1226 - 1232. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |